Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Recruiting 14Active not recruiting 11Terminated 6Withdrawn 4Not yet recruiting 3Unknown 2Enrolling by invitation 1Available 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 264Glioblastoma 193Glioma 159Neuroblastoma 56Central Nervous System Neoplasms 55Astrocytoma 45Carcinoma, Non-Small-Cell Lung 39Neoplasms 32Breast Neoplasms 27Oligodendroglioma 26Meningioma 23Recurrence 21Neuroma, Acoustic 21Neoplasm Metastasis 20Meningeal Carcinomatosis 20Gliosarcoma 20Neurofibromatosis 1 18Medulloblastoma 18Lung Neoplasms 15Paraganglioma 14Lymphoma 14Pheochromocytoma 13Spinal Cord Neoplasms 12Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Burkitt Lymphoma 9Pancreatic Neoplasms 8Ovarian Neoplasms 7Melanoma 7Esophageal Neoplasms 7

Interventions

trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neurofibroma, Plexiform × CNS × Clear all
NCT06379230 2024-04-23

A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Unknown
2,000 enrolled
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT03741101 2024-04-11

plexifpc

Region Skane

Phase 2 Unknown
15 enrolled
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡